ANA M.
MARQUEZ ORTIZ
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (16)
2023
-
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
International Journal of Molecular Sciences, Vol. 24, Núm. 17
2022
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
2021
-
HLA association with the susceptibility to anti-synthetase syndrome
Joint Bone Spine, Vol. 88, Núm. 3
-
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
Scientific Reports, Vol. 11, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
2018
-
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility
PLoS ONE, Vol. 13, Núm. 12
-
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis
PLoS ONE, Vol. 13, Núm. 5
2016
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
2015
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA
PLoS ONE, Vol. 9, Núm. 11
-
Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82
-
Influence of the IL17A locus in giant cell arteritis susceptibility
Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745
-
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis
Arthritis Research and Therapy, Vol. 16, Núm. 2
2013
-
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886